Bausch Health Companies (BHC) Raw Materials (2012 - 2018)

Bausch Health Companies has disclosed Raw Materials across 7 years of filings, most recently posting $275.0 million for Q4 2018.

• Raw Materials for Q4 2018 came in at $275.0 million, changed 0.36% year-over-year; the trailing twelve-month figure through Dec 2018 was $275.0 million (changed 0.36% YoY), and the FY2018 annual result was $275.0 million, changed 0.36% from the prior year.
• Raw Materials came in at $275.0 million for Q4 2018 at Bausch Health Companies, down from $284.0 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $290.0 million in Q1 2018 to a low of $191.1 million in Q4 2014.
• The 5-year median for Raw Materials is $275.0 million (2018), against an average of $266.2 million.
• Across the five-year window, Raw Materials retreated 13.84% in 2014 and soared 51.23% in 2015, its largest moves.
• Bausch Health Companies' Raw Materials stood at $191.1 million in 2014, then jumped by 51.23% to $289.0 million in 2015, then retreated by 11.42% to $256.0 million in 2016, then rose by 7.81% to $276.0 million in 2017, then dropped by 0.36% to $275.0 million in 2018.
• The last three Raw Materials figures came in at $275.0 million (Q4 2018), $284.0 million (Q3 2018), and $274.0 million (Q2 2018), per Business Quant data.